Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Serum soluble Fas ligand is a severity and mortality prognostic marker for COVID-19 patients

31 Aug 2022

Abstract excerpt

Finding cytokine storm initiator factors associated with uncontrolled inflammatory immune response is necessary in COVID-19 patients. The aim was the identification of Fas/Fas Ligand (FasL) role in lung involvement and mortality of COVID-19 patients. In this case-control study, mild (outpatient), moderate (hospitalized), and severe (ICU) COVID-19 patients and healthy subjects were investigated. RNA isolated from...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cell death mechanisms and regulation
Share to COVID-19 Clinical Research Studies
Share to SARS-CoV-2 and COVID-19 Research

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 36119078
DOI: 10.3389/fimmu.2022.947401

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Serum soluble Fas ligand is a severity and mortality prognostic marker for COVID-19 patientsPMID 36119078Read ↗

COVID-19 infection induces readily detectable morphological and inflammation-related phenotypic changes in peripheral blood monocytes, the severity of which correlate with patient outcomeSemantic proximity Read ↗

Blunted Fas signaling favors RIPK1-driven neutrophil necroptosis in critically ill COVID-19 patientsSemantic proximity Read ↗

Myeloid-Derived Suppressor Cells as a Potential Biomarker and Therapeutic Target in COVID-19Semantic proximity Read ↗

Neutrophil Involvement in Covid-19Semantic proximity Read ↗

Imbalanced Immune Response of T-Cell and B-Cell Subsets in Patients with Moderate and Severe COVID-19Semantic proximity Read ↗

Identification of FasL as a crucial host factor driving COVID-19 pathology and lethalitySemantic proximity Read ↗

Identifying Potential Therapeutic Targets in Long COVID Related Inflammatory, Coagulation, Mitochondrial, and Oxidative Stress Pathways through In Silico ApproachSemantic proximity Read ↗

A bioinformatic approach to investigating cytokine genes and their receptor variants in relation to COVID-19 progression.Semantic proximity Read ↗

Molecular pathways involved in COVID-19 and potential pathway-based therapeutic targetsSemantic proximity Read ↗

Identification of Robust Protein Associations With COVID-19 Disease Based on Five Clinical StudiesSemantic proximity Read ↗

COVID-19 Hyperinflammation: What about Neutrophils?Semantic proximity Read ↗

COVID-19: disease pathways and gene expression changes predict methylprednisolone can improve out- come in severe casesSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.